The AIM Healthcare index has shown positive returns in all but three out of the past 11 years (2007, 2008 and 2011), growing at a CAGR of 7.6% over the period. This compares with a CAGR of -0.3% for the broader FT AIM All Share, +0.6% for the AIM 100 and +3.5% for its more senior FT All Share Health index. Sector growth and relative performance to the AIM All Share index has accelerated over the past five years; the sector having risen 19.19% CAGR since 1 Jan 2012. This compares with 6.8% growth ....

21 Nov 2017
Rude Health
Allergy Therapeutics plc (AGY:LON), 6.5 | Bioventix Plc (BVXP:LON), 2,795 | Cambridge Nutritional Sciences PLC (CNSL:LON), 2.7 | OptiBiotix Health PLC (OPTI:LON), 20.5 | SDI Group plc (SDI:LON), 56.0 | Shield Therapeutics Plc (STX:LON), 2.5 | Tristel Plc (TSTL:LON), 372

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Rude Health
Allergy Therapeutics plc (AGY:LON), 6.5 | Bioventix Plc (BVXP:LON), 2,795 | Cambridge Nutritional Sciences PLC (CNSL:LON), 2.7 | OptiBiotix Health PLC (OPTI:LON), 20.5 | SDI Group plc (SDI:LON), 56.0 | Shield Therapeutics Plc (STX:LON), 2.5 | Tristel Plc (TSTL:LON), 372
- Published:
21 Nov 2017 -
Author:
Mark Brewer | Cavendish Research -
Pages:
36 -
The AIM Healthcare index has shown positive returns in all but three out of the past 11 years (2007, 2008 and 2011), growing at a CAGR of 7.6% over the period. This compares with a CAGR of -0.3% for the broader FT AIM All Share, +0.6% for the AIM 100 and +3.5% for its more senior FT All Share Health index. Sector growth and relative performance to the AIM All Share index has accelerated over the past five years; the sector having risen 19.19% CAGR since 1 Jan 2012. This compares with 6.8% growth ....